FDA WARNS PUBLIC AGAINST PROLIFERATION OF FAKE OVER-THE-COUNTER DRUGS IN THE MARKET

FDA WARNS PUBLIC AGAINST PROLIFERATION OF FAKE OVER-THE-COUNTER DRUGS IN THE MARKET

By Glen S. Ramos

MANILA — The Food And Drugs Administration (FDA) today issued Advisory No.2022-0941 which advises the public against the purchase and use of the counterfeit version of the following products:

  1. Mefenamic Acid (Dolfenal®) 500 mg Film-Coated Tablet
  2. Aluminum Hydroxide / Magnesium Hydroxide / Simeticone (Kremil-S®) 178 mg / 233 mg / 30 mg Chewable Tablet
  3. Naproxen Sodium (Flanax®Forte) 550 mg Tablet
  4. Ibuprofen (Medicol®Advance) 200 mg Softgel Capsule

FDA further encouraged the public to be cautious in buying medicines, especially in stores and pharmacies not duly licensed by the Department of Trade and Industry. (ai/mtvn)

Leave a Reply